Evidence map›Paper›PMID 36458588›Full record

ArticleEuropean journal of immunology2023

Toll-like receptors control the accumulation of neutrophils in lymph nodes that expand CD4

Ping Shen, Madlen Rother, Ulrik Stervbo, Vicky Lampropoulou, Elisabeth Calderon-Gomez, Toralf Roch, Ellen Hilgenberg, Steffi Ries, Anja A Kühl, Luc Jouneau and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. The immunostimulatory activity ofFrontiers in pharmacology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Ping ShenDeutsches Rheumaforschungszentrum Berlin, a Leibniz Institute, Germany.
Madlen RotherDeutsches Rheumaforschungszentrum Berlin, a Leibniz Institute, Germany.
Ulrik StervboDeutsches Rheumaforschungszentrum Berlin, a Leibniz Institute, Germany.
Vicky LampropoulouDeutsches Rheumaforschungszentrum Berlin, a Leibniz Institute, Germany.
Elisabeth Calderon-GomezDeutsches Rheumaforschungszentrum Berlin, a Leibniz Institute, Germany.
Toralf RochDeutsches Rheumaforschungszentrum Berlin, a Leibniz Institute, Germany.ORCID 0000-0003-2948-8700
Ellen HilgenbergDeutsches Rheumaforschungszentrum Berlin, a Leibniz Institute, Germany.
Steffi RiesDeutsches Rheumaforschungszentrum Berlin, a Leibniz Institute, Germany.
Anja A KühlInstitute of Pathology/RCIS, Charité, Campus Benjamin Franklin, 12203, Berlin, Germany.
Luc JouneauUniversité Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, 78350, France.
Pierre BoudinotUniversité Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, 78350, France.
Simon FillatreauDeutsches Rheumaforschungszentrum Berlin, a Leibniz Institute, Germany.ORCID 0000-0002-7730-9917
German Rheumatism Research Centre · DEUniversité de Versailles Saint-Quentin-en-Yvelines · FRCharité - Universitätsmedizin Berlin · DEHôpital Necker-Enfants Malades · FRHumboldt-Universität zu Berlin · DENational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toll-like receptors (TLR) control the activation of dendritic cells that prime CD4

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalAnimalsCD4-Positive T-LymphocytesLymph NodesMiceMice, Inbred C57BLNeutrophilsToll-Like Receptor 9Toll-Like ReceptorsToll-Like Receptor 9Toll-Like ReceptorsautoimmunityCD4+ T cellsEAEneutrophilToll-like receptor

Identifiers

PMID36458588
PMCPMC10107244
OpenAlexW4310603927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.